Compare NCEL & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCEL | CCM |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | Switzerland | China |
| Employees | 4 | 610 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 21.4M |
| IPO Year | N/A | 2009 |
| Metric | NCEL | CCM |
|---|---|---|
| Price | $3.36 | $5.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.5K | ★ 45.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.83 | $3.18 |
| 52 Week High | $5.12 | $10.77 |
| Indicator | NCEL | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 60.62 |
| Support Level | $3.03 | $4.86 |
| Resistance Level | $3.54 | $5.59 |
| Average True Range (ATR) | 0.26 | 0.53 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 55.71 | 29.18 |
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.